Many studies have reported that IL-33 upregulates programmed cell death protein 1 (PD-1) and/or PD-L1 in many tumor and immune cells, including as effector CD4+ T cells, CD8+ T cells, NK cells, and ILC2s [118,119,120]. This evidence concerns the gene IL33 and neoplasm.